5 recruiting, 1 completed, 1 not yet recruiting. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Recruiting 5, Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Recruiting 2 |
Follow High Grade Gliomas: new trials by email Literature Review of High Grade Gliomas trials Research Report on High Grade Gliomas
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors NeuroNavigation-Guided Focused Ultrasound (NgFUS), Lumason, Nivolumab - Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma, High Grade Gliomas | Phase 1 | Recruiting | Children's National Research Institute | 30 | 2026-09-01 | 2026-09-09 |
| Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma Rhenium-186 Nanoliposome - Ependymoma, High Grade Gliomas | Phase 1 | Recruiting | Cerenome | 56 | 2026-08-01 | 2026-09-11 |
| Preoperative Proton Irradiation for High-grade Brain Gliomas. Preoperative irradiation - High Grade Gliomas | Phase 1 | Recruiting | National Medical Research Radiological Centre of the Ministry of Health of Russia | 9 | 2026-07-01 | 2026-07-17 |
| Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor Gallium maltolate - High Grade Gliomas, Atypical Teratoid Rhabdoid Tumors (ATRT) | Phase 1 | Not yet recruiting | Sarah Rumler | 15 | 2026-05-15 | 2026-01-09 |
| Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma TGX-007, Valaciclovir - Glioblastoma (GBM), High Grade Gliomas | Phase 1 / Phase 2 | Recruiting | Trogenix ltd | 68 | 2026-04-21 | 2026-10-23 |
| Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). Olaparib; 177Lu-DOTATATE - Solid Tumor Cancer, Medulloblastoma | Phase 1 / Phase 2 | Recruiting | Fundación de investigación HM | 25 | 2024-09-20 | 2026-06-04 |
| SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas SM-1,TMZ - Glioma, Glioblastomas (GBM) | Phase 1 | Completed | Shenzhen Zhenxing Medical Technology Co., Ltd | 35 | 2022-09-19 | 2026-06-09 |
Glioma (4) · Glioblastoma (3) · Brain Neoplasms (2) · Diffuse Intrinsic Pontine Glioma (2) · Ependymoma (2) · Recurrence (2) · Rhabdoid Tumor (2) · Adrenal Cortex Neoplasms (1) · Adrenal Gland Neoplasms (1) · Esthesioneuroblastoma, Olfactory (1) · Medulloblastoma (1) · Meningioma (1) · Neuroblastoma (1) · Neuroendocrine Tumors (1) · Osteosarcoma (1)
Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Germ Cell and Embryonal (6) · Neoplasms, Glandular and Epithelial (6) · Neoplasms, Nerve Tissue (6) · Neoplasms, Neuroepithelial (6) · Neuroectodermal Tumors (6) · Astrocytoma (3) · Central Nervous System Neoplasms (3) · Neoplasms by Site (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Brain Diseases (2) · Brain Stem Neoplasms (2) · Central Nervous System Diseases (2)
Nivolumab (1) · Valacyclovir (1) · gallium maltolate (1) · lutetium Lu 177 dotatate (1) · olaparib (1)
Cerenome (1) · Children's National Research Institute (1) · Fundación de investigación HM (1) · National Medical Research Radiological Centre of the Ministry of Health of Russia (1) · Sarah Rumler (1) · Shenzhen Zhenxing Medical Technology Co., Ltd (1) · Trogenix ltd (1)
United States (3) · China (1) · Russia (1) · Spain (1) · United Kingdom (1)
Alexey Goryanov (1) · Igor Gulidov (1) · Marta Osuna Marco, PhD (1)